pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
VICTOZA
VICTOZA (LIRAGLUTIDE)
1 INDICATIONS AND USAGE VICTOZA is indicated: • as an adjunct to diet and exe…
Glucagon-like peptide 1 receptor
$NVONOVO NORDISK A S
0 catalysts
VIGADRONE
VIGADRONE (VIGABATRIN)
Aucta Pharmaceuticals Inc
0 catalysts
Phase 2
VIM-0423
Dystonia
Vima Therapeutics Inc
0 catalysts
Phase 1
VIPER-101
← prev
page 172 of 271
next →
131
Pain89
Neurology1
Anaplastic Large Cell Lymphoma (ALCL)
ViTToria Biotherapeutics Inc
0 catalysts
Phase 1
VIR-5500
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$VIRVir Biotechnology, Inc.
0 catalysts
Phase 1
VIR-5525
Adenocarcinoma
$VIRVir Biotechnology, Inc.
0 catalysts
Phase 1
VIS-171
Autoimmune Disorders
Visterra Inc
0 catalysts
Phase 1
VIS-954
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)
Visterra Inc
0 catalysts
Preclinical
VIS-DerMap
Basal Cell Carcinoma (Basal Cell Epithelioma)
ArrayPatch Ltd
0 catalysts
VISINE ALLERGY EYE RELIEF MULTI-ACTION
VISINE ALLERGY EYE RELIEF MULTI-ACTION (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)
KENVUE BRANDS
0 catalysts
VISIONBLUE
VISIONBLUE (TRYPAN BLUE)
DORC
0 catalysts
VITAMIN K1
VITAMIN K1 (PHYTONADIONE)
Hospira Inc
0 catalysts
VITRAKVI
VITRAKVI (LAROTRECTINIB)
BAYER HLTHCARE
0 catalysts
VIVITROL
VIVITROL (NALTREXONE)
1 INDICATIONS AND USAGE Treatment with VIVITROL should be part of a comprehen…
Opioid receptors; mu/kappa/delta
$ALKSAlkermes plc.
0 catalysts
Phase 1
VK-0214
Adrenomyeloneuropathy (AMN)
$VIKViking Holdings Ltd
0 catalysts
Phase 2
VK-5211
Bone Fracture
Androgen receptor
$VIKViking Holdings Ltd
0 catalysts
Phase 2
VL-PX10 + VL-P22
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Vitti Labs LLC
0 catalysts
Phase 3
VLA-15
Lyme Disease
$VALNValneva SE
0 catalysts
Phase 2
VLP-001
Peanut Allergy
Allergy Therapeutics Plc
0 catalysts
Phase 2
VLPM-01
Malaria
VLP Therapeutics LLC
0 catalysts
Phase 2
VLS-1488
Ovarian Cancer
Volastra Therapeutics Inc
0 catalysts
Phase 1
VMPAIN-004
Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathet…
Vivamed BioPharma
0 catalysts
Phase 2
VMPSY-002
Substance (Drug) Abuse
Vivamed BioPharma
0 catalysts
Phase 2
VMPSY-003
Opium (Opioid) Addiction
Vivamed BioPharma
0 catalysts
Phase 2
VMT-01
Metastatic Melanoma
$CATXPerspective Therapeutics, Inc.
0 catalysts
Phase 2
VMT-a-NET
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
$CATXPerspective Therapeutics, Inc.
0 catalysts
Preclinical
VNLG-152
Triple-Negative Breast Cancer (TNBC)
Isoprene Pharmaceuticals Inc
0 catalysts
Preclinical
VNRX-6355
Neisseria gonorrhoeae Infections
VenatoRx Pharmaceuticals Inc
0 catalysts
Phase 2
VNX-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Vironexis Biotherapeutics Inc
0 catalysts
Phase 2
VNX-202
Gastric Cancer
Vironexis Biotherapeutics Inc
0 catalysts